Compound Retatrutide Total strength 40mg Format Single pre-filled pen Brand Alluvi Batch AR1739JAT Stock In stock in the UK Documentation Janoshik report available Intended listing Laboratory research use only Documentation and handling notes Documentation A Retatrutide test report is linked from this product page where available so customers can review supporting quality information before ordering
Retatrutide's 24.2% was achieved 2024 weeks faster than either comparator's trial endpoint
Not for human or veterinary consumption, ingestion, injection, or any in-vivo application
A KFF tracking poll in May found 6% of US adults were currently taking a GLP-1 medication, and 1 in 8 had taken one either for weight loss or to treat a condition like diabetes
* Correspondence: Mehdi Karimi [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
CivicScience has data on over 135K GLP-1 users, providing a unique lens into these medications societal, cultural, and economic impact